Testoderm TTS CIII

Company
Alza

Approval Status
Approved December 1997

Treatment for
testosterone deficiency

Areas
Diabetes / Endocrinology

Testoderm TTS CIII has been approved for men with testosterone deficiency. It is a transdermal patch that delivers a 5-mg dose of testosterone during a 24-hour period.

Clinical Results: Clinical trials showed that application of the Testoderm patch maintained normal serum testosterone levels, with delivery comparable to the normal circadian pattern of testosterone secretion.

Testoderm_tts_ciii Drug Information

The Testoderm_tts_ciii drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top